Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bright Minds Biosciences (DRUG) Cash & Equivalents: 2019-2021

  • Bright Minds Biosciences' Cash & Equivalents was N/A to $22.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was $22.0 million, marking a year-over-year change of. This contributed to the annual value of $595,127 for FY2020, which is 882.00% up from last year.
  • Bright Minds Biosciences' Cash & Equivalents amounted to $22.0 million in Q2 2021, which was up 9.44% from $20.1 million recorded in Q1 2021.
  • Over the past 5 years, Bright Minds Biosciences' Cash & Equivalents peaked at $22.0 million during Q2 2021, and registered a low of $60,603 during Q3 2019.
  • For the 3-year period, Bright Minds Biosciences' Cash & Equivalents averaged around $8.9 million, with its median value being $1.6 million (2020).
  • Data for Bright Minds Biosciences' Cash & Equivalents shows a peak YoY skyrocketed of 890.51% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows Bright Minds Biosciences' Cash & Equivalents stood at $60,603 in 2019, then surged by 890.51% to $1.6 million in 2020, then reached $22.0 million in 2021.
  • Its Cash & Equivalents stands at $22.0 million for Q2 2021, versus $20.1 million for Q1 2021 and $1.6 million for Q4 2020.